News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Prior to FDA Vote, Advisory Committee Cites Study Bias Concerns Over Amgen (AMGN) Cancer Vaccine     4/27/2015
Celgene (CELG) Slaps Down $450 Million Upfront for AstraZeneca PLC (AZN)'s Prized Immunotherapy Blood Cancer Drug     4/24/2015
Innate Pharma (IPH.PA ) Strikes Cancer Pact Worth $1.275 Billion With Pharma Giant AstraZeneca PLC (AZN)     4/24/2015
EXCLUSIVE: Jounce CEO Says Funding Aims for Trials Next Year, Will Hire 10     4/24/2015
CAR-T Cell Companies Juno Therapeutics (JUNO), Kite Pharma (KITE), and ZIOPHARM, Inc. Get Stock Jitters on Disappointing Novartis AG (NVS) Trial News     4/22/2015
Pfizer (PFE)'s New Leukemia Drug Meets Hematologic Remission Endpoint in Phase III Study     4/22/2015
Novartis AG (NVS) Taps Cancer Guru to Head Boston R&D Group That Specializes in Immuno-Oncology     4/22/2015
Investors Suddenly Interested in Synta (SNTA) and Its Upcoming Cancer Data     4/17/2015
ThromboGenics NV (TBGNF) and VIB Form New Company to Research Roche (RHHBY)-Rejected Cancer Drug     4/16/2015
Roche (RHHBY) Says 11 Late-Stage Cancer Drugs Will Enter Trials in 2015     4/15/2015
MorphoSys AG CEO Believes Drug Isn't Dead Even After Celgene (CELG) Abandons $818 Million Pact     4/6/2015
European Regulators Postpone Bristol-Myers Squibb (BMY)’s Opdivo Decision Until April or Later, As Markets Wait Anxiously     3/31/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News     3/30/2015
CAR-T, Checkpoint Inhibitors and Vaccines All Key at Crucial Conference, Says Cowen and Company     3/27/2015
AstraZeneca PLC (AZN) Trudges Behind in Cancer Race Where Losing May Force a Buyout     3/20/2015

News from Around the Web
Turmeric May Help Treat Oral Cancers, Emory University Study     4/24/2015
Toxic Drug May Help Battle Colorectal Cancer, MD Anderson Cancer Center Study     4/23/2015
Warning: Too Many Dietary Supplements Ups Your Cancer Risk, University Of Colorado Cancer Center Study     4/23/2015
Chamomile Tea Linked To Lower Thyroid Cancer Risk, Oxford University Study     4/22/2015
Long Term, Regular Aspirin Use May Reduce Cancer Risk, Harvard School of Public Health Study     4/21/2015
Broccoli Sprout May Prevent Head and Neck Cancer, University of Pittsburgh Cancer Institute (UPCI) Study     4/20/2015
Soyfoods Reduce Breast Cancer Recurrence, University Medical Center Study     4/20/2015
How This Company Is Using Artificial Intelligence To Develop A Cure For Cancer     4/17/2015
Cancer Linked To Muscle-Building Supplements, Brown University Study     4/15/2015
New Evidence For How Green Tea And Apples Could Protect Health, Norwich BioScience Institutes Study     4/14/2015
Cancer Surge In China Prompts Rise Of Special Patient Hotels     4/13/2015
Does More Cancer Screening Cut Cancer Deaths?     4/8/2015
Saccharin Shows Promise As Cancer Inhibitor, University of Florida Researchers Find     4/1/2015
Is Hummus Good For You? 6 Health Issues The Superfood Dip Can Treat     3/31/2015
Fitness Level Associated With Lower Risk Of Some Cancers, Death In Men, University of Vermont Study     3/27/2015

Press Releases
NeoStem, Inc.'s Lead Immuno-Oncology Product Candidate, NBS20, Receives ATMP Classification From The European Medicines Agency     4/27/2015
Case Western Reserve University Release: Breakthrough Provides New Hope For More Effective Treatments For Patients With HER2+ Breast Cancer     4/24/2015
MedImmune (AZN) And Juno Therapeutics (JUNO) Announce Immuno-Oncology Clinical Trial Collaboration     4/23/2015
Biothera’s Investigational Cancer Immunotherapy Alleviates Immune Suppression By Regulatory T Cells, Enabling CD4 And CD8 T Cell Proliferation, Study Finds     4/22/2015
Verastem, Inc. (VSTM) Presents Encouraging Scientific Data On The Preferential Targeting Of Cancer Stem Cells At The 2015 AACR Annual Meeting     4/22/2015
Heat Biologics. To Present At The 2015 AACR Annual Meeting     4/22/2015
BIND Therapeutics (BIND) Presents Data Highlighting Ability Of Accurins To Control Biodistribution And Accumulate In Target Tissue At AACR Annual Meeting 2015     4/22/2015
Deciphera Pharmaceuticals Presents Data Highlighting Kinase Inhibitor Pipeline Including Proprietary And Partnered Programs At AACR 2015 Annual Meeting     4/22/2015
Strategia Therapeutics Initiates A Phase 1/2a Clinical Trial Of The Anti-Cancer Agent E6201 In Patients With Advanced Hematologic Malignancies     4/22/2015
Astellas Pharma Inc. (ALPMY) And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics     4/22/2015
Biothera’s Imprime PGG Cancer Immunotherapy Drug Candidate Shows Potential To Enhance Efficacy Of Immune Checkpoint Inhibitors     4/21/2015
Biothera’s Imprime PGG Investigational Immunotherapy Drug Modulates The Function Of Macrophages And Dendritic Cells To Drive Expansion Of Anti-Cancer T Cells     4/21/2015
New Data Demonstrate Potential Of Biothera’s Investigational Cancer Immunotherapy To Re-Orient The Tumor Microenvironment To Facilitate Greater Anti-Tumor Activity     4/21/2015
Biothera’s Investigational Cancer Immunotherapy Drug Imprime PGG Elicits Dramatic Expansion Of Cytotoxic T Cells     4/21/2015
Loxo Oncology (LOXO)'s LOXO-101 Demonstrates Encouraging Initial Results From Ongoing Phase Ia Dose Escalation Study     4/21/2015

//-->